ClinConnect ClinConnect Logo
Search / Trial NCT01787071

Fluid Challenges in Intensive Care

Launched by EUROPEAN SOCIETY OF INTENSIVE CARE MEDICINE · Feb 7, 2013

Trial Information

Current as of April 29, 2025

Completed

Keywords

Fluids Crtically Ill Patients Functional Hemodynamics Cvp

ClinConnect Summary

Introduction

Fluid Administration in Critically Ill Patients.

Fluids are one of most common therapies used in critically ill patients. Fluids are the cornerstone of hemodynamic management. In overt bleeding, fluids are often given without guidance with specific haemodynamic monitoring. In other conditions when hypovolemia may be more subtle or when the response to fluids is more variable, fluids are often given in a more titrable way, monitoring their haemodynamic impact. This practice, called the fluid challenge technique has been proposed by Max Harry Weil more than 30 years ago \[1\].
...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All consecutive adult (18 years old and above) patients , up to a maximum of 20, in whom a fluid challenge is performed during a one week period will be included
  • Exclusion Criteria:
  • 1/ Patient already included in the trial
  • 2/ Overt bleeding Patients younger than 18 year

About European Society Of Intensive Care Medicine

The European Society of Intensive Care Medicine (ESICM) is a leading professional organization dedicated to advancing the science and practice of intensive care medicine across Europe. Committed to improving patient outcomes, ESICM fosters collaborative research initiatives and clinical trials that address critical questions in intensive care. By bringing together healthcare professionals, researchers, and stakeholders, the society promotes evidence-based practices and innovative approaches to enhance the quality of care in critical settings. Through its rigorous scientific framework, ESICM aims to contribute significantly to the development and implementation of best practices in intensive care medicine.

Locations

Brussels, , Belgium

Patients applied

0 patients applied

Trial Officials

Daniel De Backer, MD,PhD

Principal Investigator

Erasme University Hospital, Brussels

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials